Bacterial contamination of cystic fibrosis clinics

被引:35
作者
Zuckerman, Jonathan B. [1 ,2 ]
Zuaro, Deborah E. [3 ]
Prato, B. Stephen [4 ]
Ruoff, Kathryn L. [3 ]
Sawicki, Rafal W. [5 ]
Quinton, Hebe B. [6 ,7 ]
Saiman, Lisa [8 ]
机构
[1] Maine Med Ctr, Div Pulm & Crit Care, Portland, ME 04102 USA
[2] Univ Vermont, Dept Med, Portland, ME USA
[3] Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03766 USA
[4] Maine Med Ctr, Dept Surg, Portland, ME 04102 USA
[5] Grand View Hosp, Sellersville, PA USA
[6] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA
[7] Dartmouth Med Sch, Lebanon, NH USA
[8] Columbia Univ, Dept Pediat, New York, NY 10027 USA
关键词
Cystic fibrosis; Infection control; Outpatient; Pseudomonas; Burkholderia; Staphylococcus; PSEUDOMONAS-AERUGINOSA INFECTION; RESISTANT STAPHYLOCOCCUS-AUREUS; FIELD GEL-ELECTROPHORESIS; BURKHOLDERIA-CEPACIA; ENVIRONMENTAL CONTAMINATION; NOSOCOMIAL ACQUISITION; INHALED TOBRAMYCIN; CROSS-INFECTION; TRANSMISSION; EPIDEMIOLOGY;
D O I
10.1016/j.jcf.2009.01.003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Respiratory pathogens from CF patients can contaminate inpatient settings, which may be associated with increased risk of patient-to-patient transmission. Few data are available that assess the rate of bacterial contamination of outpatient settings. We determined the frequency of contamination of CF clinics and the effectiveness of alcohol-based disinfectants in reducing hand carriage of bacterial pathogens. Methods: We conducted a point prevalence survey and before-after trial in outpatient clinics at 7 CF centers. The study examined CF patients with positive respiratory Cultures for Pseudomonas, Staphylococcus, Stenotrophomonas or Burkholderia species. Hand carriage and environmental contamination with respiratory pathogens were assessed during clinic visits (Part 1) and the effectiveness of hand hygiene performed by CF patients (Part II) was determined using molecular typing of recovered isolates. Results: In Part I (n=97), the contamination rate was 13.6%. Neudomonas and S. aureus, including methicillin-resistant strains, were Cultured from patients' hands (7%), the exam room air (8%), and less commonly, environmental Surfaces (1%). In Part II (n= 100), the hand carriage rate of pathogens was 13.5% and 4 participants without initial detection of pathogens had hand contamination when recultured at the end of the clinic visit. Conclusions: Respiratory pathogens from CF patients can contaminate their hands and the clinic environment, but the actual risk of patient-to-patient transmission in the Outpatient setting remains difficult to quantity. These findings support several recommendations CF infection control recommendations including hand hygiene for staff and patients, contact precautions for certain pathogens, and disinfecting equipment and surfaces touched by patients and staff. (C) 2009 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:186 / 192
页数:7
相关论文
共 49 条
  • [1] Epidemiology and clinical impact of Pseudomonas aeruginosa infection in cystic fibrosis using AP-PCR fingerprinting
    Adams, C
    Morris-Quinn, M
    McConnell, F
    West, J
    Lucey, B
    Shortt, C
    Cryan, B
    Watson, JBG
    O'Gara, F
    [J]. JOURNAL OF INFECTION, 1998, 37 (02) : 151 - 158
  • [2] [Anonymous], 2003, MMWR-MORBID MORTAL W, V52, P1
  • [3] [Anonymous], 2007, GUIDELINE ISOLATION
  • [4] Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic
    Armstrong, DS
    Nixon, GM
    Carzino, R
    Bigham, A
    Carlin, JB
    Robins-Browne, RM
    Grimwood, K
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (07) : 983 - 987
  • [5] Bosshammer J, 1995, J HOSP INFECT, V31, P261, DOI 10.1016/0195-6701(95)90205-8
  • [6] Widespread environmental contamination associated with patients with diarrhea and methicillin-resistant Staphylococcus aureus colonization of the gastrointestinal tract
    Boyce, John M.
    Havill, Nancy L.
    Otter, Jonathan A.
    Adams, Nicholas M. T.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (10) : 1142 - 1147
  • [7] BURDGE DR, 1993, INFECT CONT HOSP EP, V14, P127, DOI 10.1086/646697
  • [8] Clode FE, 1999, AM J RESP CRIT CARE, V160, P374, DOI 10.1164/ajrccm.160.1.16011
  • [9] *CYST FIBR FDN, 1994, CONS C MICR INF DIS
  • [10] DORING G, 1991, ZBL HYG UMWELTMED, V191, P494